NCT07220746 Understanding Cognitive-Academic Bidirectionality in Math Learning Disabilities
| NCT ID | NCT07220746 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vanderbilt University |
| Condition | Math Learning Disability |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2030-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-08-01 with a primary completion date of 2030-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test the effects of an innovative intervention designed to improve math skills in first graders at risk for math disabilities. The main questions the trial aims to answer are: * Does combining a math word problem solving intervention with a working memory intervention improve math to a greater extent than the same math intervention without cognitive training? * Do the findings provide evidence for bidirectional effects on development? In other words, does working memory support math learning and does math learning support working memory development? Screening for eligibility will take place in two testing sessions. Students who meet the eligibility criteria will be randomly assigned to one of three groups: 1. One treatment group will receive a validated treatment for math word problem solving plus computerized working memory training. 2. Another treatment group will receive the same validated math treatment plus computerized reading instruction. 3. A control group will receive the conventional school math program, including any additional school-provided intervention. Participants in both treatment groups will receive 35 minutes of tutoring three times per week for 15 weeks. Children who are selected to participate in the study will be tested once before this project's intervention begins; twice after intervention starts; twice after intervention ends; and once near the end of second grade to see how long effects last.
Eligibility Criteria
Inclusion Criteria: * Attends a participating school in the Metropolitan-Nashville Public Schools * Is a member of a first-grade classroom whose teacher has agreed to let his/her students participate * Has the available school schedule to participate * Scores below the 30th percentile on the study's screening math test * Scores below the 50th percentile on the study's working memory test * Scores at or above the 7th percentile on at least one of the study's two measures of cognitive performance Exclusion Criterion: * Does not attend a participating school in the Metropolitan-Nashville Public Schools * Is not a member of a first-grade classroom whose teacher has agreed to let his/her students participate * Does not have the available school schedule to participate * Scores at or above 30th percentile on the study's screening math test * Scores at or above the 50th percentile on the study's screening working test * Scores below the 7th percentile on both of the study's two measures of cognitive performance
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07220746 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 8 Years, studying Math Learning Disability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07220746 currently recruiting?
Yes, NCT07220746 is actively recruiting participants. Contact the research team at c.f.craddock@vanderbilt.edu for enrollment information.
Where is the NCT07220746 trial being conducted?
This trial is being conducted at Nashville, United States.
Who is sponsoring the NCT07220746 clinical trial?
NCT07220746 is sponsored by Vanderbilt University. The trial plans to enroll 300 participants.